covid-19 |
53 |
sars-cov-2 |
46 |
mucosal immunity |
17 |
neutralizing antibody |
16 |
receptor binding domain |
16 |
live attenuated vaccine |
15 |
ace2 |
14 |
human immunodeficiency virus |
14 |
transmission |
14 |
vaccine |
14 |
inactivated vaccine |
13 |
rnai |
13 |
sace2 |
13 |
animal |
12 |
coronavirus |
12 |
spike protein |
12 |
2′-o-methyltransferase |
11 |
adult |
11 |
anthranilic acid |
11 |
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
broad spectrum |
11 |
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
endoplasmic reticulum |
11 |
influenza a virus |
11 |
neutralizing antibodies |
11 |
nsp16 |
11 |
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
severe acute respiratory syndrome - drug therapy |
11 |
sterilizing immunity |
11 |
t-cell response |
11 |
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
disease severity |
10 |
human neutralizing antibody |
10 |
immunity |
10 |
linker-immunodominant site |
10 |
lung injury |
10 |
male |
10 |
nasal turbinate |
10 |
phage display |
10 |
upper respiratory tract |
10 |
ba.5.2 |
9 |
coronavac |
9 |
fc-rbd |
9 |
genotype |
9 |
immune protection |
9 |
omicron variant |
9 |
sars-cov-2 variants of concern |
9 |
xbb.1 |
9 |
age |
8 |
aged |
8 |
animals |
8 |
antibody blood level |
8 |
antibody titer |
8 |
b-cell suppression |
8 |
delns1-ncov-rbd laiv |
8 |
intranasal |
8 |
mice |
8 |
mice, inbred balb c |
8 |
mitochondrial dysfunction |
8 |
phase-1 |
8 |
spike mutant |
8 |
spike s1/s2 mutant |
8 |
t cell exhaustion |
8 |
acute infection |
7 |
administration, oral |
7 |
antibodies, viral - blood - immunology |
7 |
antibody |
7 |
convalescent |
7 |
covid19 |
7 |
dendritic cell |
7 |
furin cleavage prra motif |
7 |
hiv-1 |
7 |
icu patient |
7 |
immunization, secondary |
7 |
injections, intramuscular |
7 |
neutralization tests |
7 |
reinfection |
7 |
sars virus - immunology |
7 |
vaccines, dna - administration & dosage - immunology |
7 |
viral variants |
7 |
astrovirus |
6 |
bacterial vaccines - administration & dosage - immunology |
6 |
escherichia coli proteins |
6 |
humans |
6 |
immunization schedule |
6 |
immunoglobulin g - blood |
6 |
injections, intraperitoneal |
6 |
interferon-gamma - analysis |
6 |
interleukin-4 - analysis |
6 |
live-attenuated influenza-based vaccine |
6 |
membrane glycoproteins - administration & dosage - genetics - immunology |
6 |
memory t cell |
6 |
mitochondrial dysfunction (md) |
6 |
models, animal |
6 |
nasal prevention |
6 |
pd1-based dna vaccine |
6 |
phylogenetic tree |
6 |
rodents |
6 |
severe acute respiratory syndrome - prevention & control |
6 |
t-cell functionality |
6 |
vaccines, synthetic - administration & dosage - immunology |
6 |
viral envelope proteins - administration & dosage - genetics - immunology |
6 |
virus discovery |
6 |
whole genome |
6 |
ace2 expression and distribution |
5 |
adenosinergic signaling pathway |
5 |
children |
5 |
china |
5 |
cytokines |
5 |
entpd1/cd39 |
5 |
et5e/cd73 |
5 |
extracellular adenosine |
5 |
highly active antiretroviral therapy |
5 |
immune response |
5 |
immunoglobulins |
5 |
immunotherapy |
5 |
infectious disease |
5 |
lung development |
5 |
lung progenitor cells |
5 |
macrophages |
5 |
mdscs |
5 |
molecular epidemiology |
5 |
monoclonal antibody |
5 |
mutation |
5 |
patients’ ages |
5 |
pd1 |
5 |
pulmonology |
5 |
sars-cov-2 virus |
5 |
vulnerability |
5 |
animal model |
4 |
antigen spreading |
4 |
cd8+t cells |
4 |
cd8-positive t-lymphocytes - immunology - virology |
4 |
cellular immune response |
4 |
chimpanzee adenovirus vector |
4 |
china - epidemiology |
4 |
crf01-ae |
4 |
ctls |
4 |
dna vaccine |
4 |
drug resistance, viral - genetics |
4 |
drug susceptibility |
4 |
entry inhibitor |
4 |
epidemics |
4 |
female |
4 |
general population |
4 |
genes, gag |
4 |
genes, pol |
4 |
hiv |
4 |
hiv core protein p24 - immunology |
4 |
hiv infections - complications - epidemiology - virology |
4 |
hiv infections - prevention and control |
4 |
hiv-1 - classification - drug effects - genetics |
4 |
hiv-1 - classification - genetics - physiology |
4 |
hiv-1 - immunology |
4 |
hiv-1 - pathogenicity |
4 |
humoral immune response |
4 |
immunology and microbiology section |
4 |
influenza vaccines |
4 |
interferon-gamma - metabolism |
4 |
memory cd8 t cell response |
4 |
mesothelioma |
4 |
middle aged |
4 |
modelling |
4 |
modified vaccinia tiantan |
4 |
monocytes - virology |
4 |
mrna vaccine |
4 |
ns1 |
4 |
persistent virus infection |
4 |
phylogeny |
4 |
pregnancy |
4 |
pregnancy complications, infectious - epidemiology |
4 |
prevalence |
4 |
programmed cell death 1 receptor - immunology |
4 |
protective immunity |
4 |
recombination, genetic |
4 |
replication capacity |
4 |
sanguisorba officinalis |
4 |
sars-cov-2 vaccine |
4 |
sexual transmission |
4 |
single-dose immunization |
4 |
suppressor of cytokine signaling proteins - genetics |
4 |
traditional chinese medicine |
4 |
transcriptional activation |
4 |
vaccination |
4 |
virotherapy |
4 |
young adult |
4 |
adeno-associated virus |
3 |
aids |
3 |
allergology and immunology |
3 |
amino acid motifs |
3 |
amino terminal sequence |
3 |
animal experiment |
3 |
animal tissue |
3 |
anti-hiv agents - chemical synthesis - pharmacology |
3 |
antibodies, neutralizing - genetics - immunology |
3 |
bcg |
3 |
beropt |
3 |
binding sites |
3 |
blood donors |
3 |
cells, cultured |
3 |
clinical article |
3 |
combination antiretroviral therapy |
3 |
ctla-4 |
3 |
cytotoxic t lymphocytes |
3 |
d42pd1 |
3 |
dna, recombinant - genetics |
3 |
drug resistance, viral - drug effects |
3 |
drug synergism |
3 |
epithelial cells - virology |
3 |
escc |
3 |
genetic variation |
3 |
hepacivirus - classification - genetics |
3 |
hepatitis c - epidemiology - virology |
3 |
hiv infections - drug therapy - virology |
3 |
hiv infections - epidemiology - transmission |
3 |
hiv infections - epidemiology - virology |
3 |
hiv reverse transcriptase - antagonists and inhibitors - genetics - metabolism |
3 |
hiv-1 - classification - genetics |
3 |
hiv-1 - drug effects |
3 |
hiv-1 - drug effects - enzymology - genetics |
3 |
humanized mouse |
3 |
immune checkpoint blockade |
3 |
immunity, mucosal - immunology |
3 |
immunohistochemistry |
3 |
integrin 4β7 |
3 |
leukocytes, mononuclear - drug effects - virology |
3 |
medical sciences |
3 |
microbial sensitivity tests |
3 |
models, molecular |
3 |
mycobacterium tuberculosis |
3 |
neutralization |
3 |
nevirapine - pharmacology |
3 |
pd-1 |
3 |
pd1-based vaccination |
3 |
pyranocoumarins - chemical synthesis - pharmacology |
3 |
reverse transcriptase inhibitors - chemical synthesis - pharmacology |
3 |
rm-act-1 |
3 |
salivary ducts - virology |
3 |
sars |
3 |
sars virus - isolation and purification - pathogenicity |
3 |
sars-cov |
3 |
severe acute respiratory syndrome - veterinary - virology |
3 |
smallpox vaccine - administration and dosage - immunology |
3 |
soluble pd1-based vaccination |
3 |
t cell immunity |
3 |
tuberculosis |
3 |
tumor |
3 |
twist1 antigen |
3 |
vaccinia |
3 |
vaccinia - immunology - prevention and control |
3 |
vaccinia virus - genetics |
3 |
vaccinia virus - genetics - immunology |
3 |
vedolizumab |
3 |
virus replication - drug effects |
3 |
35b5 |
2 |
adcc |
2 |
administration, intranasal |
2 |
aids (艾滋病) |
2 |
amino acid substitution - genetics |
2 |
anti-hiv agents - chemical synthesis - chemistry - pharmacology |
2 |
antibodies, monoclonal - immunology - isolation and purification - therapeutic use |
2 |
antibodies, neutralizing - immunology |
2 |
antibodies, viral - biosynthesis |
2 |
antibodies, viral - chemistry |
2 |
antibodies, viral - immunology - isolation and purification - therapeutic use |
2 |
antibody somatic maturation |
2 |
antigenic shift |
2 |
apoptosis |
2 |
bacillus calmette-guérin |
2 |
cannabinoids |
2 |
ccr7 |
2 |
cd4 t cells |
2 |
cd4-induced |
2 |
cdna |
2 |
cell biology |
2 |
cell culture |
2 |
cell isolation |
2 |
cell line |
2 |
central memory cd4 t cells |
2 |
chimeric |
2 |
chinese macaques |
2 |
chinese rhesus monkey |
2 |
chromones - chemical synthesis - chemistry - pharmacology |
2 |
combinatorial chemistry techniques |
2 |
communicable diseases medical sciences |
2 |
coumarins - chemical synthesis - chemistry - pharmacology |
2 |
crf01_ae |
2 |
crf07_bc |
2 |
cross-protection |
2 |
disease models, animal |
2 |
disease progression |
2 |
dissociation |
2 |
dna methylation |
2 |
dna, viral - genetics |
2 |
drug resistance |
2 |
effector/effector memory cd4 t cells |
2 |
epitope |
2 |
fujian |
2 |
gene deletion |
2 |
gene expression |
2 |
genes, viral |
2 |
genetic vectors |
2 |
genome |
2 |
genomic dna |
2 |
germline antibodies |
2 |
glycan |
2 |
green fluorescent proteins - genetics |
2 |
gut-homing t cell |
2 |
haart |
2 |
hand |
2 |
hela cells |
2 |
hemagglutinin |
2 |
highly pathogenic avian influenza virus |
2 |
hiv infection |
2 |
hiv infections - drug therapy - genetics |
2 |
hiv-1 - drug effects - genetics |
2 |
hiv-1 - genetics |
2 |
hiv-1 latent infection |
2 |
human monoclonal antibody |
2 |
ige+b cell |
2 |
immunology |
2 |
in vivo protection |
2 |
influenza vaccine |
2 |
influenza viruses |
2 |
lung pathogenesis |
2 |
macaca mulatta - virology |
2 |
membrane glycoproteins - antagonists and inhibitors - chemistry - immunology |
2 |
membrane glycoproteins - chemistry - genetics - immunology |
2 |
membrane glycoproteins - immunology |
2 |
microscopy |
2 |
monoclonal antibodies |
2 |
msm |
2 |
mucosal vaccine |
2 |
mutagenesis |
2 |
mvtt |
2 |
mvtt zci |
2 |
newly emerging h5 viruses |
2 |
nsg |
2 |
nucleocapsid proteins - immunology |
2 |
omicron |
2 |
peptidyl-dipeptidase a - chemistry - genetics - metabolism |
2 |
pyranocoumarins - chemical synthesis - chemistry - pharmacology |
2 |
rabbits |
2 |
rbd |
2 |
receptor-binding domain |
2 |
receptors, ccr5 - physiology |
2 |
receptors, virus - physiology |
2 |
recombinant fusion proteins |
2 |
rhesus macaque |
2 |
sars virus - genetics - immunology |
2 |
sars virus - immunology - physiology |
2 |
sars virus - physiology |
2 |
severe acute respiratory syndrome - enzymology - pathology - virology |
2 |
severe acute respiratory syndrome - immunology - physiopathology |
2 |
shiv |
2 |
simian acquired immunodeficiency syndrome - virology |
2 |
siv |
2 |
smallpox |
2 |
smallpox - immunology - prevention and control |
2 |
smallpox vaccine - administration and dosage - biosynthesis - genetics - immunology |
2 |
stereoisomerism |
2 |
structure-activity relationship |
2 |
subtype b' |
2 |
t-cell differentiation |
2 |
terminal repeat sequences - genetics |
2 |
th1 |
2 |
th17 |
2 |
thc |
2 |
tiantan |
2 |
tissue-resident memory t cell |
2 |
transmitted/founder |
2 |
treg |
2 |
v2 |
2 |
vaccine (疫苗) |
2 |
vaccinia (痘苗) |
2 |
vaccinia tian tan |
2 |
vaccinia tiantan (天坛痘苗) |
2 |
vaccinia virus - genetics - immunology - pathogenicity |
2 |
vaccinia virus - genetics - immunology - pathogenicity - physiology |
2 |
viral envelope proteins - antagonists and inhibitors - chemistry - immunology |
2 |
viral envelope proteins - chemistry - genetics - immunology |
2 |
viral envelope proteins - immunology |
2 |
viral vaccines - genetics - immunology - metabolism |
2 |
viral vector |
2 |
viral vector (病毒载体) |
2 |
virus internalization |
2 |
virus replication |
2 |
virus replication - drug effects - genetics |
2 |
virus replication - genetics |
2 |
acquired immunodeficiency syndrome - drug therapy |
1 |
acquired immunodeficiency syndrome - epidemiology - genetics |
1 |
acquired immunodeficiency syndrome - virology |
1 |
acute disease |
1 |
ad5 |
1 |
adaptation, physiological |
1 |
adenoviruses, human - genetics - immunology |
1 |
adjuvant |
1 |
adjuvants, immunologic - administration & dosage |
1 |
admva |
1 |
adolescent |
1 |
advax |
1 |
africa, western |
1 |
aids vaccines - administration & dosage - genetics - immunology |
1 |
aids vaccines - administration and dosage - adverse effects - immunology |
1 |
aids vaccines - immunology |
1 |
amino acid sequence |
1 |
amino acid substitution |
1 |
animals, domestic - virology |
1 |
antagonists |
1 |
anti-hiv |
1 |
anti-hiv agents - administration & dosage - chemical synthesis - pharmacokinetics |
1 |
anti-hiv agents - chemistry - pharmacology - therapeutic use |
1 |
antibodies, viral - blood |
1 |
antibody specificity |
1 |
antigen binding |
1 |
antigens, cd - immunology |
1 |
antigens, cd - physiology |
1 |
antigens, cd1 - genetics |
1 |
antigens, cd1d |
1 |
antigens, cd4 - physiology |
1 |
antigens, differentiation - immunology |
1 |
antigens, viral - chemistry - genetics |
1 |
antiretroviral |
1 |
antiretroviral drug |
1 |
antiretroviral therapy |
1 |
antiviral activity |
1 |
base sequence |
1 |
bi-bnab |
1 |
biia-sg |
1 |
binding affinity |
1 |
binding site |
1 |
biological availability |
1 |
biological characterization |
1 |
blood transfusion - adverse effects |
1 |
blotting, western |
1 |
brain - virology |
1 |
calanolide a |
1 |
cancer immunobiology |
1 |
cancer-associated fibroblast |
1 |
ccr2b |
1 |
ccr5 |
1 |
ccr5 receptor |
1 |
cd34 + progenitor cells |
1 |
cd4 lymphocyte count |
1 |
cd4+ lymphocytopenia |
1 |
cd4+ tcm cells |
1 |
cd4-positive t-lymphocytes |
1 |
cd4-positive t-lymphocytes - cytology - immunology |
1 |
cd4-positive t-lymphocytes - immunology |
1 |
cd4-positive t-lymphocytes - immunology - virology |
1 |
cd8-positive t-lymphocytes - cytology - immunology |
1 |
cd8-positive t-lymphocytes - immunology |
1 |
cdna synthesis |
1 |
cdna合成 |
1 |
cell activation |
1 |
cell adhesion molecules |
1 |
cell adhesion molecules - metabolism |
1 |
cell dysfunction |
1 |
cell line, transformed |
1 |
cellular immunity |
1 |
cellular immunology |
1 |
cercocebus |
1 |
cercocebus - virology |
1 |
cercocebus atys - virology |
1 |
cervix uteri - immunology - virology |
1 |
chemical resolution |
1 |
chemokines - immunology |
1 |
child |
1 |
child, preschool |
1 |
cloning, molecular |
1 |
cluster analysis |
1 |
coculture techniques |
1 |
cohort studies |
1 |
conditional gene expression |
1 |
conditional splicing |
1 |
conserved sequence |
1 |
cordatolide a |
1 |
coreceptor |
1 |
coreceptor switch |
1 |
cos cells |
1 |
crf (circulating recombination forms) |
1 |
cross reactions |
1 |
cross reactions - genetics - immunology |
1 |
cxcr4 |
1 |
cytokines - biosynthesis |
1 |
cytopathogenic effect, viral |
1 |
cytotoxic t lymphocyte |
1 |
dendritic cells - immunology |
1 |
dendritic cells - metabolism - virology |
1 |
disease outbreaks |
1 |
dna |
1 |
dna demethylating agents |
1 |
dna primers - genetics |
1 |
dna, viral - chemistry - genetics |
1 |
dogs |
1 |
dose-response relationship, immunologic |
1 |
dose-sparing |
1 |
double-blind method |
1 |
dual promoter dna vaccine |
1 |
emigration and immigration |
1 |
enantioselectivity |
1 |
endothelium, vascular - metabolism - virology |
1 |
enzyme-linked immunosorbent assay |
1 |
epithelial cells - ultrastructure - virology |
1 |
ethnic groups - statistics & numerical data |
1 |
evolution, molecular |
1 |
fibroblasts - ultrastructure - virology |
1 |
fibrosis |
1 |
fms-related tyrosine kinase 3 ligand |
1 |
gabon |
1 |
gag gene products, human immunodeficiency virus - immunology |
1 |
galactosylceramides - administration & dosage |
1 |
gene products, env - analysis |
1 |
gene products, env - genetics - immunology - metabolism |
1 |
gene products, env - genetics - metabolism |
1 |
gene products, env - genetics - physiology |
1 |
gene products, env - metabolism |
1 |
gene products, gag - analysis |
1 |
gene products, gag - chemistry - genetics |
1 |
gene products, gag - genetics - immunology - metabolism |
1 |
gene products, nef - genetics - immunology - metabolism |
1 |
gene products, pol - genetics - immunology - metabolism |
1 |
gene products, tat - genetics - immunology - metabolism |
1 |
genes - genetics |
1 |
genes, env |
1 |
genes, gag - genetics |
1 |
genes, vpu |
1 |
genetic predisposition to disease |
1 |
genome, viral |
1 |
global health |
1 |
glycosylation |
1 |
healthy individuals |
1 |
henan |
1 |
hepacivirus - genetics - metabolism - pathogenicity |
1 |
hepatocellular carcinoma |
1 |
heterocycles |
1 |
heterologous vaccine |
1 |
heterozygote detection |
1 |
histone deacetylase inhibitors |
1 |
hiv - genetics - metabolism |
1 |
hiv antibodies - biosynthesis |
1 |
hiv antibodies - blood |
1 |
hiv envelope protein gp120 - immunology |
1 |
hiv envelope protein gp160 - genetics |
1 |
hiv fusion inhibitors - chemistry - pharmacology - therapeutic use |
1 |
hiv infections - drug therapy |
1 |
hiv infections - epidemiology - prevention & control - transmission |
1 |
hiv infections - epidemiology - prevention & control - transmission - virology |
1 |
hiv infections - epidemiology - transmission - virology |
1 |
hiv infections - genetics - virology |
1 |
hiv infections - immunology - physiopathology - transmission - virology |
1 |
hiv infections - immunology - transmission - virology |
1 |
hiv infections - metabolism |
1 |
hiv infections - prevention & control |
1 |
hiv infections - virology |
1 |
hiv integrase inhibitors - chemistry - pharmacology - therapeutic use |
1 |
hiv long-term survivors |
1 |
hiv protease inhibitors - chemistry - pharmacology - therapeutic use |
1 |
hiv seroprevalence |
1 |
hiv-1 - classification - genetics - isolation & purification |
1 |
hiv-1 - classification - metabolism - pathogenicity |
1 |
hiv-1 - genetics - immunology |
1 |
hiv-1 - genetics - isolation & purification |
1 |
hiv-1 - genetics - metabolism - pathogenicity |
1 |
hiv-1 - isolation & purification - pathogenicity - physiology |
1 |
hiv-1 - physiology |
1 |
hiv-1 infections |
1 |
hiv-1 subtype |
1 |
hiv-2 - classification - genetics - immunology |
1 |
hiv-2 - classification - immunology |
1 |
hiv-2 - immunology |
1 |
hiv-2 - physiology |
1 |
homozygote |
1 |
hubei |
1 |
immigrants |
1 |
immune breadth |
1 |
immune potency |
1 |
immunity, cellular - drug effects |
1 |
immunization |
1 |
immunization - methods |
1 |
immunization, secondary - methods |
1 |
infected patients |
1 |
infection |
1 |
infectious disease transmission, vertical |
1 |
injections, intravenous |
1 |
integrins |
1 |
interferon-gamma - immunology |
1 |
interferon-gamma - secretion |
1 |
interferon-γ |
1 |
intestines - immunology |
1 |
jak/stat |
1 |
kinetics |
1 |
lectins - metabolism |
1 |
lectins, c-type - metabolism |
1 |
leukocytes, mononuclear - immunology |
1 |
leukocytes, mononuclear - virology |
1 |
liver immunology |
1 |
loxp-splice-loxp |
1 |
lymph nodes - cytology - immunology |
1 |
lymphopenia - immunology - virology |
1 |
macaca |
1 |
macaca mulatta |
1 |
macaca mulatta (恒河猴) |
1 |
macaca nemestrina |
1 |
macaque |
1 |
macaques |
1 |
major antigenic determinant |
1 |
malaria - immunology - prevention and control |
1 |
malaria vaccines - immunology |
1 |
mangabey |
1 |
maturation |
1 |
membrane fusion |
1 |
membrane glycoproteins - chemistry - genetics - immunology - physiology |
1 |
membrane glycoproteins - genetics |
1 |
membrane glycoproteins - genetics - immunology - metabolism |
1 |
membrane glycoproteins - genetics - metabolism |
1 |
membrane glycoproteins - metabolism |
1 |
mice, inbred strains |
1 |
mice, knockout |
1 |
microscopy, electron |
1 |
models, chemical |
1 |
molecular cloning |
1 |
molecular sequence data |
1 |
molecular structure |
1 |
monocyte |
1 |
mosaic gag antigen |
1 |
mucosal vaccination |
1 |
mucous membrane - immunology |
1 |
multiple-site vaccination |
1 |
mutagenesis, site-directed |
1 |
mutation - genetics |
1 |
mva |
1 |
myeloid-derived immune suppressive cells |
1 |
new york city |
1 |
nkt cells |
1 |
nyc |
1 |
organ specificity |
1 |
overlapping genes |
1 |
paid blood donor |
1 |
passage |
1 |
pathogenesis |
1 |
peptidyl-dipeptidase a - genetics - metabolism |
1 |
phenotype |
1 |
photobiotin probe |
1 |
plasmids - genetics |
1 |
plasmodium berghei - genetics - immunology |
1 |
polymerase chain reaction |
1 |
polymorphism, genetic |
1 |
polysaccharides - immunology |
1 |
primary hiv-1 infection |
1 |
promoter regions, genetic - genetics |
1 |
prostitution - statistics & numerical data |
1 |
protein binding |
1 |
protein structure, tertiary |
1 |
pyrrolidines - administration & dosage - chemical synthesis - pharmacokinetics |
1 |
raccoon dogs |
1 |
rapid progression |
1 |
rats |
1 |
reassortant viruses - genetics |
1 |
receptors, ccr1 |
1 |
receptors, ccr2 |
1 |
receptors, ccr3 |
1 |
receptors, ccr5 |
1 |
receptors, ccr5 - antagonists & inhibitors |
1 |
receptors, ccr5 - deficiency - genetics - physiology |
1 |
receptors, ccr5 - genetics - immunology |
1 |
receptors, ccr5 - genetics - physiology |
1 |
receptors, ccr5 - metabolism |
1 |
receptors, cell surface - metabolism |
1 |
receptors, chemokine - genetics - immunology |
1 |
receptors, chemokine - genetics - physiology |
1 |
receptors, cxcr4 - genetics - physiology |
1 |
receptors, cytokine - genetics - metabolism |
1 |
receptors, cytokine - genetics - physiology |
1 |
receptors, hiv - genetics - metabolism |
1 |
receptors, hiv - metabolism |
1 |
receptors, hiv - physiology |
1 |
receptors, interferon - deficiency |
1 |
receptors, virus - genetics - metabolism |
1 |
receptors, virus - genetics - physiology |
1 |
receptors, virus - metabolism |
1 |
recombinant proteins - biosynthesis |
1 |
rectal mucosal infection |
1 |
regulation system |
1 |
retroviridae proteins - genetics - immunology - metabolism |
1 |
reverse transcriptase inhibitors - chemistry - pharmacology - therapeutic use |
1 |
reverse transcriptase polymerase chain reaction |
1 |
rhesus macaques |
1 |
rhesus monkey viral antibody simian retrovirus |
1 |
risk factors |
1 |
rna, viral - blood |
1 |
rt gene mutation |
1 |
rt-shiv |
1 |
rural population |
1 |
sars virus - genetics |
1 |
sars virus - genetics - immunology - pathogenicity - physiology |
1 |
sentinel surveillance |
1 |
sequence alignment |
1 |
sequence analysis, dna |
1 |
sequence deletion |
1 |
sequence homology |
1 |
sequence homology, amino acid |
1 |
severe acute respiratory syndrome - immunology - prevention & control - virology |
1 |
sex ratio |
1 |
sexually transmitted diseases, viral - immunology - transmission - virology |
1 |
shivchn19p4 |
1 |
simian acquired immunodeficiency syndrome - etiology - immunology - virology |
1 |
simian acquired immunodeficiency syndrome - genetics - immunology |
1 |
simian acquired immunodeficiency syndrome - immunology - physiopathology - transmission - virology |
1 |
simian acquired immunodeficiency syndrome - immunology - virology |
1 |
simian immunodeficiency virus |
1 |
simian immunodeficiency virus - classification |
1 |
simian immunodeficiency virus - classification - genetics - immunology |
1 |
simian immunodeficiency virus - classification - metabolism - pathogenicity |
1 |
simian immunodeficiency virus - genetics - immunology - isolation & purification |
1 |
simian immunodeficiency virus - genetics - isolation and purification |
1 |
simian immunodeficiency virus - genetics - metabolism |
1 |
simian immunodeficiency virus - genetics - metabolism - pathogenicity |
1 |
simian immunodeficiency virus - genetics - pathogenicity - physiology |
1 |
simian immunodeficiency virus - immunology |
1 |
simian immunodeficiency virus - isolation & purification - pathogenicity - physiology |
1 |
simian immunodeficiency virus - isolation & purification - physiology |
1 |
simian immunodeficiency virus - physiology |
1 |
simian/human immunodeficiency virus |
1 |
sivmac239 |
1 |
sivrcm |
1 |
smallpox vaccine |
1 |
solubility |
1 |
southern hybridization |
1 |
southern雜交 |
1 |
species specificity |
1 |
spleen - cytology - immunology - metabolism |
1 |
srv-1 |
1 |
substance abuse, intravenous - epidemiology |
1 |
substance use disorders |
1 |
subtype b′ |
1 |
subtype c |
1 |
t-lymphocytes |
1 |
tak-779 |
1 |
tissue tropism |
1 |
transfection |
1 |
transgenic plasmodium berghei |
1 |
transmitted drug resistance |
1 |
vaccination route |
1 |
vaccines, attenuated - administration and dosage - adverse effects |
1 |
vaccines, dna - administration & dosage - genetics |
1 |
vaccines, dna - administration & dosage - genetics - immunology |
1 |
vaccines, dna - immunology |
1 |
vaccines, dna - immunology - pharmacology |
1 |
vaccines, subunit - immunology |
1 |
vaccinia - physiopathology - virology |
1 |
vaccinia vector |
1 |
vaccinia virus - classification - growth & development - pathogenicity - ultrastructure |
1 |
vaccinia virus - genetics - physiology |
1 |
vagina - virology |
1 |
vaginal transmission |
1 |
viral envelope proteins - chemistry - genetics - immunology - physiology |
1 |
viral envelope proteins - genetics |
1 |
viral envelope proteins - genetics - immunology - metabolism |
1 |
viral envelope proteins - genetics - metabolism |
1 |
viral envelope proteins - metabolism |
1 |
viral genome engineering |
1 |
viral load |
1 |
viral matrix proteins - immunology |
1 |
viral vaccines - administration & dosage - genetics |
1 |
viral vaccines - administration & dosage - genetics - immunology |
1 |
viremia |
1 |
viremia - blood |
1 |
virulence |
1 |
virulence - genetics - immunology - physiology |
1 |
virus assembly |
1 |
virus attachment |
1 |
virus cultivation |
1 |
virus replication - drug effects - physiology |
1 |
virus replication - immunology |
1 |
viruses |
1 |
weight loss |
1 |
yeast surface display |
1 |
yunnan |
1 |
zidovudine - pharmacology |
1 |
α-galactosylceramide |
1 |
δ24 defect |
1 |
δ42pd1 |
1 |
光敏生物素探針 |
1 |
分子克隆 |
1 |
恒河猴 |
1 |
病毒抗體 |
1 |
直腸黏膜感染 |
1 |
細胞免疫應答 |
1 |